Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filipe Cirne

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Urology|June 4, 2021
Editorial CommentFilipe Cirne, Darryl P Leong
CASE (Philadelphia, Pa.)|October 29, 2021
Beyond the Wires: A Case of Leadless Pacemaker-Mediated Tricuspid RegurgitationFilipe Cirne, Omid Salehian, Douglas Wright
The Canadian Journal of Cardiology|April 28, 2024
Recurrent Pericardial Effusions and Thrombi Secondary to Angiosarcoma: Adding to the Differential of Pericardial DiseasesPaul Mundra, Richard Whitlock, Omar Ibrahim, et al.
Cardiology Clinics|November 17, 2024
Cardiovascular Risk in Prostate CancerDarryl P Leong, Filipe Cirne, Jehonathan H Pinthus
The Israel Medical Association Journal : IMAJ|March 29, 2022
The Cardiologist's Role in the Management of Patients with a Genitourinary CancerFilipe Cirne, Som D Mukherjee, Jehonathan Pinthus, et al.
Arquivos Brasileiros De Cardiologia|November 28, 2024
Primary Percutaneous Coronary Intervention during Off-Hours: One-Decade Experience from a High-Volume Cardiovascular CenterFilipe Cirne, Marcia Moura Schmidt, Cristiano Oliveira Cardoso, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysisFilipe Cirne, Coralea Kappel, Shijie Zhou, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 20, 2021
The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancerFilipe Cirne, Nazanin Aghel, Jo-Anne Petropoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2021
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysisFilipe Cirne, Shijie Zhou, Coralea Kappel, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Urology|June 4, 2021
Editorial CommentFilipe Cirne, Darryl P Leong
CASE (Philadelphia, Pa.)|October 29, 2021
Beyond the Wires: A Case of Leadless Pacemaker-Mediated Tricuspid RegurgitationFilipe Cirne, Omid Salehian, Douglas Wright
The Canadian Journal of Cardiology|April 28, 2024
Recurrent Pericardial Effusions and Thrombi Secondary to Angiosarcoma: Adding to the Differential of Pericardial DiseasesPaul Mundra, Richard Whitlock, Omar Ibrahim, et al.
Cardiology Clinics|November 17, 2024
Cardiovascular Risk in Prostate CancerDarryl P Leong, Filipe Cirne, Jehonathan H Pinthus
The Israel Medical Association Journal : IMAJ|March 29, 2022
The Cardiologist's Role in the Management of Patients with a Genitourinary CancerFilipe Cirne, Som D Mukherjee, Jehonathan Pinthus, et al.
Arquivos Brasileiros De Cardiologia|November 28, 2024
Primary Percutaneous Coronary Intervention during Off-Hours: One-Decade Experience from a High-Volume Cardiovascular CenterFilipe Cirne, Marcia Moura Schmidt, Cristiano Oliveira Cardoso, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysisFilipe Cirne, Coralea Kappel, Shijie Zhou, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 20, 2021
The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancerFilipe Cirne, Nazanin Aghel, Jo-Anne Petropoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2021
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysisFilipe Cirne, Shijie Zhou, Coralea Kappel, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Pageof 2